Further typical molecular alterations of TNBC are the loss of function of BRCA1 gene and p53 mutations, both considered to be biomarkers of a breast cancer risk and a worse prognosis for breast cancer patients [4,5]. This evidence concerns the gene TP53 and breast cancer.